相关实验视频

Updated: May 16, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

解决影响种族少数群体的心血管健康差异的技术干预:机遇和挑战

Audrey Todd¹, Carl J Lavie², Shady Abohashem³

¹Stanford University School Medicine, 291 Campus Drive, Stanford, CA 94305, USA; Health Disparities Think Tank, USA.

Trends in cardiovascular medicine

|April 1, 2025

概括

少数民族面临更高的心血管疾病 (CVD) 风险. 数字健康工具 (mHealth) 是有前途的,但需要社区伙伴关系,提高数字素养,以及更好地获得公平的采用.

科学领域:

公共卫生公共卫生
健康差异在健康上的差异
数字健康公平数字健康公平

背景情况:

与白人美国人相比,种族少数群体的心血管疾病 (CVD) 发生率不成比例地高.
促成因素包括社会经济劣势,危险的生活环境和有限的医疗保健准入.

研究的目的:

探索数字健康 (mHealth) 技术在少数群体中治疗心血管疾病的潜力.
识别障碍,并提出解决方案,以实现在代表性不足的社区中公平地采用移动健康.

主要方法:

审查关于移动健康采用和健康差异的现有文献.
分析诸如数字健康素养,文化相关性和医疗保健不信任等挑战.

主要成果:

移动健康为个性化健康管理和社区参与提供了一个有前途的途径.
显著的障碍阻碍了少数群体的广泛采用,包括数字素养差距和不信任.

结论:

政策干预对于促进以社区为中心的移动健康发展至关重要.
提高数字健康素养和确保公平获取是减少心血管疾病差异的关键.

关键词:

心血管疾病是什么心血管疾病在健康方面存在差异.卫生政策卫生政策这里是Mehalth mhealth.

更多相关视频

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology

Published on: September 28, 2022

相关概念视频

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...

Assessment of the Cardiovascular System I: Subjective Data

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...